Metabolomics Provides Insights into Renoprotective Effects of Semaglutide in Obese Mice

PURPOSE: Semaglutide, a new long-acting glucagon-like peptide-1 analogue, has shown benefits for renal diseases, but its direct role on kidney metabolism under obesity remains unclear. The study aims to elucidate the protective effect and metabolic modulation mechanism of semaglutide on obesity-rela...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xing, Chen, Shuchun, Ren, Qingjuan, Niu, Shu, Pan, Xiaoyu, Yue, Lin, Li, Zelin, Zhu, Ruiyi, Jia, Zhuoya, Chen, Xiaoyi, Zhen, Ruoxi, Ban, Jiangli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656502/
https://www.ncbi.nlm.nih.gov/pubmed/36388084
http://dx.doi.org/10.2147/DDDT.S383537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656502/
https://www.ncbi.nlm.nih.gov/pubmed/36388084
http://dx.doi.org/10.2147/DDDT.S383537

Ejemplares similares